Goldstein, R.E. , Epstein, S.E.: Medical Management of patients with angina pectoris. Prog. Cardiovasc. Dis., 14: 360, 1972.
2.
Rivier, J.L.: Beta-blockers in the treatment of angina pectoris, in Beta—Blockers—Present Status and Future Prospects. Edited by W. Schweitzer.Bern, Stuttgart, Vienna, Hans Huber Publishers, 1974 , p. 193.
3.
Louis, W.J., Morgan, T.O., Anavekar, S.N., et al.: Evaluation of MK-950 as an anti-hypertension agent, in Beta-Adrenergic Blocking Agents in the Management of Hypertension and Angina Pectoris. Edited by B. Magnani.New York, Raven Press Publishers , 1974, p. 19.
4.
Brailovsky, D.: Timolol maleate (MK-950): A new beta blocking agent for the prophylactic management of angina pectoris. A multi-center, multinational cooperative trial, in Beta-Adrenergic Blocking Agents in the Management of Hypertension and Angina Pectoris. Edited by B. Magnani.New York, Raven Press Publishers , 1974, p. 117.
5.
Villa, I., Dagenais, G.R., Dorian, W.D., et al.: Effect of timolol on exercise tolerance in patients with angina pectoris, in Beta-Adrenergic Blocking Agents in the Management of Hypertension and Angina Pectoris. Edited by B. Magnani.New York, Raven Press Publishers, 1974, p. 153.
6.
Achong, M.R. , Plafsky, K.M., Ogilvie, R.I.: Comparison of cardiac effects of timolol and propranolol. Clin. Pharmacol. Ther., 18: 278, 1975.
7.
Hall, R.A., Rodson, R.D., Share, N.N.: A new potent β adrenergic blocking agent, 3 morpholino-4-(3-t butylamino-2-hydroxypropoxy) 1-2-5 thiadiazole maleate. Proc. Can. Fed. Biol. Soc., 13: 33, 1970.
8.
Warembourg, H., Ginestet, A., Carre, A.: Etude clinique d'un nouvel anti-angineux: Le maleate de timolol. Lille Med. Actuel., 22: 280, 1977 (Suppl. 1).
9.
Ulrych, M., Franciosa, J., Conway, J.: Comparison of a new beta adrenergic blocker (MK-950) and propranolol in man . Clin. Pharmacol. Ther., 13: 232, 1972.
10.
Brodgen, R.N. , Speight, T.M., Avery, G.S.: Timolol (Blocadren-Frosst-MSD): An independent preliminary report. New Ethic. Med. Prog., 12: 27, 1975.
